Sanofi agrees to buy Synthorx in $2.5 billion deal
MLex Summary: Sanofi and Synthorx have agreed to combine in a $2.5 billion deal that Sanofi said would bolster its immuno-oncology pipeline. The merger is expected to close in the first...To view the full article, register now.
Already a subscriber? Click here to view full article